With 9.38 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.93 million shares. During the session, the Diagnostics & Research company that operates in wider Healthcare sector, reached to the highest price of $1.96 whereas the lowest price it dropped to was $1.61. The 52-week range on MBAI shows that it touched its highest point at $3.13 and its lowest point at $0.56 during that stretch. It currently has a 1-year price target of $7.00. Beta for the stock currently stands at 0.44.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of MBAI was up-trending over the past week, with a rise of 38.52%, but this was up by 28.97% over a month. Three-month performance surged to 154.80% while six-month performance rose 128.83%. The stock gained 88.91% in the past year, while it has gained 128.69% so far this year.
Float and Shares Shorts:
At present, 5.85 million MBAI shares are outstanding with a float of 5.56 million shares on hand for trading. On 2025-11-14, short shares totaled 0.18 million, which was 310.0 higher than short shares on 1760486400. In addition to Mr. David Lontini as the firm’s Interim CEO & Chairman of the Board, Ms. Noa Reshef M.B.A. serves as its Head of Operations.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. The surprise factor in the prior quarter was -$0.53.
